Cargando…
Addressing fundamental questions on MIS-C
Autor principal: | Davies, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9765418/ https://www.ncbi.nlm.nih.gov/pubmed/33711292 http://dx.doi.org/10.1016/S2352-4642(21)00059-6 |
Ejemplares similares
-
Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs
por: Crosby, Laura, et al.
Publicado: (2021) -
Lower risk of Multi-system inflammatory syndrome in children (MIS-C) with the omicron variant
por: Lopez, Laura, et al.
Publicado: (2022) -
IL-1 receptor antagonist, MIS-C, and the peculiar autoimmunity of SARS-CoV-2
por: Bassiri, Hamid, et al.
Publicado: (2022) -
The wrong questions
por: Dua, Alisha
Publicado: (2020) -
Open questions on chemistry in the synthesis and characterization of superheavy elements
por: Steinegger, Patrick
Publicado: (2021)